You ask the questions - we develop the answers.

We combine professional management with scientific expertise.

The Institute for Pharmacology and Preventive Medicine

The Institute is an experienced partner of universities, non-university institutions, health insurance companies, and pharmaceutical companies in the implementation of scientific projects in the fields of cardiovascular disease and diabetes.

Icon Klinische Register

Registries / Studies

Registries and studies across Europe are our expertise.

read more

Icon Prüfzentrum

Validation Centre

We validate the accuracy of your blood pressure monitors.

read more

Icon Beratung

Consulting

Trustworthy advice of a medical doctor and a pharmacist.

read more

IPPMed Partnership

Prof. Dr. Peter Bramlage (physician) and Dr. Johannes Hankowitz (pharmacist) work closely together in the Institute for Pharmacology and Preventive Medicine, Dr. Bramlage & Dr. Hankowitz Partnership. Dr Bramlage focuses on collaboration with partners from industry and universities on scientific questions and the evaluation and publication of study data. Dr Hankowitz is experienced in the preparation and assessment of drug evaluations within the AMNOG (Pharmaceuticals Market Reorganisation Act) and editor of AMNOG-monitor.

IPPMed GmbH

Our activities in the areas of clinical registries and validation of blood pressure monitoring devices are a part of IPPMed – Institute for Pharmacology and Preventive Medicine GmbH. This is managed by Prof. Dr. Peter Bramlage and Dr. Beate Beime. Here, together with the highly experienced staff at our office in Cloppenburg, we regularly carry out large scale projects involving the latest pharmaceuticals and medical devices.
The close collaboration with clients, as well as with external investigators, ensures the high quality of our work. We focus primarily on cardiovascular indications, hypertension, thrombosis, and diabetes.

Project Manager wanted!


We are looking for a project manager in the field of registries / studies for our office located in Cloppenburg.

Recent Activity / Publications in press



Zemmrich C, Bramlage P, Hillmeister P, Scirovic M, Buschmann I. Risk factor management in non-metropolitan patients with coronary and peripheral artery disease – a prospective, multi-center, quality improvement strategy. VHRM 2021

Grünewald M, Häge E, Lehnert S, Maier C, Schimke A, Bramlage P, Güth M. Prophylactic anticoagulation with intermediate-dose certoparin in vascular-risk pregnancies – the PACER-VARP registry. CATH 2021

Dempfle CE, Koscielny J, Lindhoff-Last E, Linnemann B, Bux-Gewehr I, Kappert G, Scholz U, Krapff S, Eberle S, Bramlage P, Heinken A. Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thromboembolism (FondaPPP). CATH 2021

van Mark G, Tittel SR, Welp R, Gloyer J, Sziegoleit S, Barion R, Jehle PM, Erath D, Bramlage P, Lanzinger S. The DIVE/DPV registries: Benefits and risks of analogue insulin use in individuals 75 years and older with type 2 diabetes mellitus. BMJ Open Diabetes Research & Care 2021.

Steffens D, Bramlage P, Müller J, Dorn C, Paar WD, Scheef C, Kasner M, Rauch-Kröhnert U. Intensified Lipid-Lowering Treatment with Alirocumab in Patients with Coronary Heart Disease. Open Heart 2021.

Studencan M, Pella D, Bramlage P, Kaszasova E. Clinical characteristics and management of hyperlipoproteinemia in patients with chronic coronary heart disease in Slovakia. Archives of Medical Science 2021.

PubMed listed Publications


Our Partners


logo S4TRAILS
Logo da-cro
Logo Antepuls

Logo IHF
logo Beate Beime Pharma Consulting